abstract |
Compositions and methods for the treatment of eye diseases in a subject are provided. In one aspect, an adeno-associated viral vector comprising a nucleic acid molecule comprising a sequence encoding CNGA3 is provided. In another aspect, an adeno-associated viral vector comprising a nucleic acid molecule comprising a sequence encoding CNGB3 is provided. In another aspect, an adeno-associated viral vector comprising a nucleic acid molecule comprising a sequence encoding REP-1. In desirable embodiments, the subject is a human, cat, dog, sheep or non-human primate. |